Source: BioSpace

Recyte Therapeutics: ReCyte Therapeutics, Inc., A BioTime Subsidiary, Announces Peer-Reviewed Publication On Pericyte-Like Progenitor Cells

Life Sciences Jobs ...

Read full article »
Recyte Therapeutics's Competitors | Recyte Therapeutics's News | Recyte Therapeutics's Financials
Stay up-to-date with the latest news on ReCyte Therapeutics, Inc.
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Michael D West's photo - CEO of ReCyte Therapeutics, Inc.

CEO

Michael D West

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on ReCyte Therapeutics, Inc.